SEC Filing Summary: Form 13F-HR
Business Context and Reporting Period
This filing is a Form 13F-HR submitted by Johnson & Johnson (Institutional Investment Manager) for the quarter ended June 30, 2026. The report discloses the equity securities held by the manager and includes one other included manager: Johnson & Johnson Innovation - JJDC, Inc.
Key Financial Metrics
As a Form 13F filing, this document reports portfolio holdings rather than the operating financial performance (revenue, profit, cash flow) of Johnson & Johnson itself. The following metrics relate to the reported investment portfolio:
- Total Portfolio Value: $798,650,757
- Total Number of Holdings: 15
- Number of Other Included Managers: 1
Note: The filing text does not provide values for revenue, profit, margins, debt, or liquidity as these are not applicable to a 13F holdings report.
Material Changes
The filing text does not provide comparative data for the prior period; therefore, material changes in holdings or portfolio value versus the previous quarter cannot be determined from this document alone.
Guidance, Outlook, and Risks
Form 13F filings are statutory disclosures of holdings and do not contain management commentary, forward-looking guidance, risk factors, or contingencies regarding the company's business operations.
Investor Verification Checklist
- Verify the total portfolio value of $798,650,757 against the sum of individual security values in the full schedule.
- Confirm the inclusion of the subsidiary manager, Johnson & Johnson Innovation - JJDC, Inc., and ensure its holdings are properly aggregated.
- Review the specific list of 15 equity holdings to assess concentration risk or strategic investment shifts.
- Note that this filing reflects investment activity, not the operating results of Johnson & Johnson.